Quantitative evaluation of the clinical effects of s-adenosylmethionine on mood and behavior in lesch-nyhan patients

Nucleosides, Nucleotides and Nucleic Acids

Volumn 32, Issue 4, 2013, Pages 174-188

  Dolcetta, Diego ^a   Parmigiani, Pietro ^a   Salmaso, Luigi ^b   Bernardelle, Roberta ^c   Cesari, Ugo ^d   Andrighetto, Gilberto ^a   Baschirotto, Giuseppe ^a   Nyhan, William L ^e   Hladnik, Uros ^a  

^a BIRD Foundation   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c BIRD Rehabilitation   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Lesch Nyhan disease; resistance to heteroinjurious behavior test; resistance to self injurious behavior test; S adenosylmethionine; weekly questionnaire

Indexed keywords

HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; S ADENOSYLMETHIONINE;

ADULT; ARTICLE; AUTOMUTILATION; BEHAVIOR DISORDER; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG SCREENING; DRUG TOLERANCE; DRUG WITHDRAWAL; HUMAN; LESCH NYHAN SYNDROME; MOOD DISORDER; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; VOMITING;

ADOLESCENT; ADULT; AFFECT; BEHAVIOR; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; LESCH-NYHAN SYNDROME; MIDDLE AGED; PSYCHOTROPIC DRUGS; QUESTIONNAIRES; S-ADENOSYLMETHIONINE; TREATMENT OUTCOME;

EID: 84876150005     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770.2013.774012     Document Type: Article

References (32)

1. Torres, R.J.; Puig, J.G. Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome. Orphanet J. Rare Dis. 2007, 2, 48.
2. Seegmiller, J.E. Inherited deficiency of hypoxanthine-guanine phosphoribosyltransferase in Xlinked uric aciduria (the Lesch-Nyhan syndrome and its variants). Adv. Hum. Genet 1976, 6, 75-163.
3. Nyhan, W.L.;O'Neill, J.P.; Jinnah, H.A.; Harris, J.C. Lesch-Nyhan Syndrome. in GeneReviews, eds. R.A. Pagon, T.C. Bird, C.R. Dolan, K. Stephens, University of Washington, Seattle, WA, 1993 [updated 2010 Jun 10]).
4. Lesch, M.; Nyhan, W.L. A familial disorder of uric acid metabolism and central nervous system function. Am. J. Med. 1964, 36, 561-570.
5. Visser, J.E.; Harris, J.C.; Barabas, G.; Eddey, G.E.; Jinnah, H.A. The motor disorder of classic Lesch-Nyhan disease. Nucleos. Nucleot. Nucl. 2004, 23, 1161-1164. (Pubitemid 39625887)
6. Jinnah, H.A.; Ceballos-Picot, I.; Torres, R.J.; Visser, J.E.; Schretlen, D.J.; Verdu, A.; Larovere, L.E.; Chen, C.J.; Cossu, A.; Wu, C.H.; Sampat, R.; Chang, S.J.; de Kremer, R.D.; Nyhan, W.; Harris, J.C.; Reich, S.G.; Puig, J.G.; Lesch-Nyhan Disease International Study Group. Attenuated variants of Lesch-Nyhan disease. Brain 2010, 133, 671-689.
7. Glick, N. Dramatic reduction in self-injury in Lesch-Nyhan disease following S-adenosylmethionine administration. J. Inherit. Metab. Dis. 2006, 29, 687.
8. Bottiglieri, T. S-Adenosyl-L-methionine (SAMe): from the bench to the bedside-molecular basis of a pleiotrophic molecule. Am. J. Clin. Nutr. 2002, 76, 1151S-1157S. (Pubitemid 35244694)
9. Mischoulon, D.; Fava, M. Role of S-adenosyl-L-methionine in the treatment of depression: A review of the evidence. Am. J. Clin. Nutr. 2002, 76, 1158S-1161S. (Pubitemid 35244695)
10. Andreescu, C.; Mulsant, B.H.; Emanuel, J.E. Complementary and alternative medicine in the treatment of bipolar disorder-a review of the evidence. J. Affect Disord. 2008, 110, 16-26.
11. Pancheri, P.; Scapicchio, P.; Chiaie, R.D. A double-blind, randomized parallel-group, efficacy and safety study of intramuscular S-adenosyl-L- methionine 1,4-butanedisulphonate (SAMe) versus imipramine in patients with major depressive disorder. Int. J. Neuropsychopharmacol, 2002, 5, 287-294. (Pubitemid 35470348)
12. Strous, R.D.; Ritsner, M.S.; Adler, S.; Ratner, Y.; Maayan, R.; Kotler, M.; Lachman, H.; Weizman, A. Improvement of aggressive behavior and quality of life impairment following S-adenosyl-methionine (SAM-e) augmentation in schizophrenia. Eur. Neuropsychopharmacol. 2009, 19, 14-22.
13. Silver, J.M.; Yudofsky, S.C. The overt aggression scale: Overview and guiding principles. J. Neuropsychiatry Clin. Neurosci. 1991, 3, S22-S29.
14. Rojahn, J.; Matson, J.L.; Lott, D.; Esbensen, A.J.; Smalls, Y. The behavior problems inventory: An instrument for the assessment of self-injury, stereotyped behavior, and aggression/destruction in individuals with developmental disabilities. J. Autism. Dev. Disord. 2001, 31, 577-588. (Pubitemid 37490154)
15. Goulet, L.R.; Barclay, A. The vineland social maturity scale: Utility in assessment of Binet MA. Am. J. Ment. Defic. 1963, 67, 916-921.
16. de Gemmis, P.; Anesi, L.; Lorenzetto, E.; Gioachini, I.; Fortunati, E.; Zandona, G.; Fanin, E.; Fairbanks, L.; Andrighetto, G.; Parmigiani, P.; Dolcetta, D.; Nyhan, W.L.; Hladnik, U. Analysis of the HPRT1 gene in 35 Italian Lesch-Nyhan families: 45 patients and 77 potential female carriers. Mutat. Res. 2010, 692, 1-5.
17. Pesarin, F. S. L. Permutation Ttests for Complex Data: Theory, Applications and Software-Theory, Applications and Software. John Wiley and Sons, London, 2010.
18. Brombin, C.; Midena, E.; Salmaso, L. Robust non-parametric tests for complex-repeated measures problems in ophthalmology. Stat. Methods Med. Res. 24 Jun 2011.
19. Bottiglieri, T.; Laundy, M.; Crellin, R.; Toone, B.K.; Carney, M.W.; Reynolds, E.H. Homocysteine, folate, methylation, and monoamine metabolism in depression. J. Neurol. Neurosurg. Psychiatry 2000, 69, 228-232. (Pubitemid 30466029)
20. Mizuno, T.I.; Yugari, Y. Letter: Self mutilation in Lesch-Nyhan syndrome. Lancet 1974, 1, 761.
21. Frith, C.D.; Johnston, E.C.; Joseph, M.H.; Powell, R.J.; Watts, R.W. Double-blind clinical trial of 5-hydroxytryptophan in a case of Lesch-Nyhan syndrome. J. Neurol. Neurosurg. Psychiatry 1976, 39, 656-662.
22. Nyhan, W.L.; Johnson, H.G.; Kaufman, I.A.; Jones, K.L. Serotonergic approaches to themodification of behavior in the Lesch-Nyhan Syndrome. Appl. Res. Ment. Retard. 1980, 1, 25-40.
23. Jinnah, H.A.; Gage, F.H.; Friedmann, T. Amphetamine-induced behavioral phenotype in a hypoxanthine-guaninephosphoribosyltransferase-deficient mouse model of Lesch-Nyhan syndrome. Behav. Neurosci. 1991, 105, 1004-1012.
24. Miller, A.L. The methylation, neurotransmitter, and antioxidant connections between folate and depression. Altern. Med. Rev. 2008, 13, 216-226.
25. Boison, D.; Singer, P.; Shen, H.Y.; Feldon, J.; Yee, B.K. Adenosine hypothesis of schizophrenia-opportunities for pharmacotherapy. Neuropharmacology. 2012, 62, 1527-1543.
26. Shen,H.Y.; Singer, P.; Lytle, N.;Wei, C.J.; Lan, J.Q.;Williams-Karnesky, R.L.; Chen, J.F.; Yee, B.K.; Boison, D. Adenosine augmentation ameliorates psychotic and cognitive endophenotypes of schizophrenia. J. Clin. Invest. 2012, 2, 2567-2577.
27. Guibinga, G.H.; Hrustanovic, G.; Bouic, K.; Jinnah, H.A.; Friedmann, T. MicroRNA-mediated dysregulation of neural developmental genes in HPRT deficiency: Clues for Lesch-Nyhan disease? Hum. Mol. Genet. 2012, 1(21), 609-622.
28. Kang, T.H.; Guibinga, G.H.; Jinnah, H.A.; Friedmann, T. HPRT deficiency coordinately dysregulates canonical Wnt and presenilin-1 signaling: AA neuro-developmental regulatory role for a housekeeping gene? PLoS One. 2011, 28(6), e16572.
29. Erratum in: PLoS One. 2011, 6(3).
30. Garć?a, M.G.; Puig, J.G.; Torres, R.J. Adenosine, dopamine and serotonin receptors imbalance in lymphocytes of Lesch-Nyhan patients. J. Inherit. Metab. Dis. 2012, 35(6), 1129-1135.
31. Jinnah, H.A.; Visser, J.E.; Harris, J.C.; Verdu, A.; Larovere, L.; Ceballos-Picot, I.; Gonzalez-Alegre, P.; Neychev, V.; Torres, R.J.; Dulac, O.; Desguerre, I.; Schretlen, D.J.; Robey, K.L.; Barabas, G.; Bloem, B.R.; Nyhan, W.; De Kremer, R.; Eddey, G.E.; Puig, J.G.; Reich, S.G. Lesch-Nyhan Disease International Study Group. Delineation of the motor disorder of Lesch-Nyhan disease. Brain 2006, 129, 1201-1217.
32. Anderson, L.T.; Ernst, M. Self-injury in Lesch-Nyhan disease. J. Autism. Dev. Disord. 1994, 24, 67-81. (Pubitemid 24065611)